Disease presentation and outcome in young patients (<40 years) with brain metastases from malignant melanoma

Anticancer Research

Volumn 28, Issue 2 B, 2008, Pages 1325-1327

  Nieder, Carsten ^a,b   Adam, Markus ^c   Astner, Sabrina T ^d  

^a Nordlandssykehuset HF   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c Radiation Oncology Practice   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Age; Brain metastasis; Malignant melanoma; Prognostic factors; Radiotherapy

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; HUMAN; MALE; MELANOMA; PRIORITY JOURNAL; SURVIVAL TIME;

ADULT; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; MALE; MELANOMA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 42549098987     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Khuntia D, Brown P, Li J and Mehta MP: Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol 24: 1295-1304, 2006.
2. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, Harman R, Zacest AC, Besser M and Thompson JF: Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 22: 1293-1300, 2004.
3. Bafaloukos D and Gogas H: The treatment of brain metastases in melanoma patients. Cancer Treat Rev 30: 515-520, 2004.
4. Daponte A, Ascierto PA, Gravina A, Melucci M, Scala S, Ottaiano A, Simeone E, Palmieris G and Cornelia G: Temozolomide and cisplatin in advanced malignant melanoma. Anticancer Res 25: 1441-1447, 2005.
5. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG and Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37: 745-751, 1997.
6. Selek U, Chang EL, Hassenbusch SJ IIIrd, Shiu AS, Lang FF, Allen P, Weinberg J, Sawaya R and Maor MH: Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 59: 1097-1106, 2004.
7. Boogerd W, de Gast GC and Dalesio O: Temozolomide in advanced malignant melanoma with small brain metastases: can we withhold cranial irradiation? Cancer 109: 306-312, 2007.
8. Meier S, Baumert BG, Maier T, Wellis G, Burg G, Seifert B and Dummer R: Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie 27: 145-149, 2004.
9. Mathieu D, Kondziolka D, Cooper PB, Flickinger JC, Niranjan A, Agarwala S, Kirkwood J and Lunsford LD: Gamma knife radiosurgery in the management of malignant melanoma brain metastases. Neurosurgery 60: 471-481, 2007.
10. Samlowski WE, Watson GA, Wang M, Rao G, Klimo P Jr, Boucher K, Shrieve DC and Jensen RL: Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery. Cancer 109: 1855-1862, 2007.
11. Koc M, McGregor J, Grecula J, Bauer CJ, Gupta N and Gahbauer RA: Gamma knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neurooncol 71: 307-313, 2005.
12. Hofmann M, Kiecker F, Wurm R, Schlenger L, Budach V, Sterry W and Trefzer U: Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases. J Neurooncol 76: 59-64, 2006.
13. Gonzalez Cao M, Malvehy J, Marti R, Conill C, Sanchez M, Martin M, Mellado B, Castel T and Puig S: Biochemotherapy with temozolomide, cisplatin, vinblastine, subcutaneous interleukin-2 and interferon-alpha in patients with metastatic melanoma. Melanoma Res 16: 59-64, 2006.
14. Fountzilas G, Kalofonos HP, Aravantinos G, Tsoutsos D, Panagiotou P, Frangia K, Petrakopoulou T and Pectasides D; Hellenic Cooperative Oncology Group: Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year - a Hellenic Cooperative Oncology Group study. Anticancer Res 24: 1947-1952, 2004.
15. Majer M, Jensen RL, Shrieve DC, Watson GA, Wang M, Leachman SA, Boucher KM and Samlowski WE: Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. Cancer 110: 1329-1337, 2007.